Progress in therapeutic targets on podocyte for Alport syndrome
- PMID: 38812923
- PMCID: PMC11135632
- DOI: 10.2478/jtim-2024-0005
Progress in therapeutic targets on podocyte for Alport syndrome
Keywords: Alport syndrome; podocyte; therapeutic targets.
Conflict of interest statement
Conflict of Interest None declared.
Figures
Similar articles
-
Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.Kidney Int. 2017 Dec;92(6):1515-1525. doi: 10.1016/j.kint.2017.05.017. Epub 2017 Jul 26. Kidney Int. 2017. PMID: 28754557 Free PMC article.
-
Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome.Front Cell Dev Biol. 2023 Mar 2;11:1111424. doi: 10.3389/fcell.2023.1111424. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36936689 Free PMC article.
-
Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.J Pathol. 2012 Jan;226(1):120-31. doi: 10.1002/path.2979. Epub 2011 Sep 26. J Pathol. 2012. PMID: 21953121
-
Alport syndrome--insights from basic and clinical research.Nat Rev Nephrol. 2013 Mar;9(3):170-8. doi: 10.1038/nrneph.2012.259. Epub 2012 Nov 20. Nat Rev Nephrol. 2013. PMID: 23165304 Review.
-
Expert consensus guidelines for the genetic diagnosis of Alport syndrome.Pediatr Nephrol. 2019 Jul;34(7):1175-1189. doi: 10.1007/s00467-018-3985-4. Epub 2018 Jul 9. Pediatr Nephrol. 2019. PMID: 29987460 Review.
Cited by
-
A comprehensive splicing characterization of COL4A5 mutations and prognostic significance in a single cohort with X-linked alport syndrome.Front Genet. 2025 Jun 11;16:1564343. doi: 10.3389/fgene.2025.1564343. eCollection 2025. Front Genet. 2025. PMID: 40567900 Free PMC article.
References
-
- Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018;93:1045. et al. –. - PubMed
-
- Xie J, Wu X, Ren H, Wang W, Wang Z, Pan X. COL4A3 mutations cause focal segmental glomerulosclerosis. J Mol Cell Biol. 2014;6:498. et al. –. - PubMed
LinkOut - more resources
Full Text Sources